Semglee OverviewInsulin glargine, marketed under the names Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes. It is typically the recommended long acting insulin in the United Kingdom. It is used once a day as an injection just under the skin. Effects generally begin an hour after use. Common side effects include low blood sugar, problems at the site of injection, itchiness, and weig...
Read more Semglee Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Insulin_glargine
Recent Semglee Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 100 Units/ml, 100unit/ml, 300 Units/ml
- Solution: 300 Units/3ml (100 Units/ml), 300 Units/ml (300 Units/ml), 300units/ml (300units/ml), 450 Units/1.5ml (300 Units/ml), 900 Units/3ml (300 Units/ml)
NDC Database Records for Semglee: (2 results)Sorted by National Drug Code
- 49502-195 Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p.
- 49502-196 Semglee 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p.
Other drugs which contain Insulin Glargine or a similar ingredient: (5 results)
- BASAGLAR Insulin Glargine1 discussion
- INSULIN GLARGINE
- TOUJEO Insulin Glargine
- INSULIN GLARGINE + LIXISENATIDE
- SOLIQUA Insulin Glargine + Lixisenatide